While US ECM market share is consolidating among a few large banks, Cowen has managed to differentiate its practice by supporting companies through their growth stages and beyond, making it IFR’s US ...

With its market-leading biotech franchise and efforts in related sectors enabling it to crack the top 10 in US ECM, Cowen is IFR’s US Mid-Market Equity House of the Year ... Cowen’s senior research ...